Latest Monoamine oxidase inhibitors Stories
RESEARCH TRIANGLE PARK, N.C., Nov. 2, 2010 /PRNewswire/ -- CeNeRx BioPharma, Inc., today announced that a new formulation of TriRima(TM), its lead agent for treatment resistant depression, showed excellent safety in a study designed to test whether it is free of the food-induced cardiovascular effects associated with conventional MAO inhibitors. These positive results further confirm the good safety profile demonstrated by TriRima in Phase I studies and set the stage for a TriRima Phase II...
Early Saint Louis University research explores curative power of curcuminCurcumin, a chemical that gives curry its zing, holds promise in preventing or treating liver damage from an advanced form of a condition known as fatty liver disease, new Saint Louis University research suggests.Curcurmin is contained in turmeric, a plant used by the Chinese to make traditional medicines for thousands of years. SLU's recent study highlights its potential in countering an increasingly common kind of...
Extra-virgin olive oil can protect the liver from oxidative stress. Researchers writing in BioMed Central's open access journal Nutrition and Metabolism exposed rats to a moderately toxic herbicide known to deplete antioxidants and cause oxidative stress, finding that those rats fed on a diet containing the olive oil were partially protected from the resulting liver damage.Mohamed Hammami from the University of Monastir, Tunisia and King Saud University, Riyadh, Saudi Arabia, worked with a...
HAYWARD, Calif., Oct. 22 /PRNewswire/ -- CREAGRI, Inc.® (www.CREAGRI.com), a world leader in providing the highest quality polyphenol antioxidants captured from organic olives, recently unveiled a new hydroxytyrosol formulation specifically developed for inclusion in consumer goods. The new particulate-free formula, HIDROX® 12%, is the latest addition to CREAGRI's® impressive line of natural, organic olive polyphenolic ingredients, which includes HIDROX® Liquid (0.5%),...
Curcumin, the major component in the spice turmeric, when combined with the drug Cisplatin enhances the chemotherapy's suppression of head and neck cancer cell growth, researchers with UCLA's Jonsson Cancer Center have found.A naturally occurring spice widely used in South Asian and Middle Eastern cooking, Turmeric has long been known to have medicinal properties, attributed to its anti-inflammatory effects. Previous studies have shown it can suppress the growth of certain cancers, said Dr....
ROCHESTER, N.Y., Sept. 22/PRNewswire/ -- Researchers at the Capital Medical University in Beijing have found that epigallocatechin-3-gallate (EGCG), a compound found abundantly in green tea, is able to kill cervical cancer cells and prevent them from forming. The authors of the study state that EGCG "has shown its anti-tumor ability and perhaps as potential regimen for cancer patients(1)." This is great news for many women, as the National Cancer Institute projects that in 2010 over 12,000...
GREEN BAY, Wis., Sept. 16 /PRNewswire/ -- Top researchers at the Gastrointestinal Cancer Research Lab at Baylor University Medical Center in Dallas are exploring the clinical applications of BCM-95®, a new patented extract of curcumin with unprecedented potency, and bioavailability. Previous studies have shown that BCM-95 curcumin was 7-10 times more bioavailable than other forms of curcumin, and had a retention time in the bloodstream between 8 to 12 hours.(1) At all points in the...
AUSTIN, Texas, Sept. 15 /PRNewswire-USNewswire/ -- A new clinical trial supports the benefits to people with osteoarthritis who used a unique extract of turmeric. [1] Scientists in Italy have studied the pain-relief, increased flexibility, and other effects of a special, patented extract of the roots of turmeric, the flavorful spice that has been used for centuries as a traditional remedy. Turmeric formulations have shown a wide range of safety and significant scientific and clinical...
RESEARCH TRIANGLE PARK, N.C., Aug. 13 /PRNewswire/ -- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced completion of a $13 million Series C financing. Existing investors Perseus Soros Biopharmaceutical Fund, L Capital Partners and Pappas Ventures all participated in the financing. CeNeRx plans to use the proceeds to conduct a Phase II trial of its improved formulation of...
ENGLEWOOD CLIFFS, N.J., July 12 /PRNewswire/ -- New research has found that people who consume relatively high amounts of flavonols have a lower risk of stroke. Tea was most likely the major contributor of flavonols in the diet, ranging from 30 percent (US) to 70 percent (the Netherlands) of the total intake. Flavonols are a subclass of flavonoids. Flavonoids are dietary compounds found in tea, wine, cocoa, fruit and vegetables. They contribute significantly to taste, color and possibly...
